Neoadjuvant chemotherapy for ovarian cancer: do we have enough evidence?

被引：23
|
作者：
Kang, Sokbom [1 ]
机构：
[1] Natl Canc Ctr, Goyang 411769, South Korea
来源：
LANCET | 2015年 / 386卷 / 9990期
关键词：
D O I：
10.1016/S0140-6736(14)62259-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 224
页数：2
相关论文
共 50 条
  • [1] Do we have enough evidence to insist we have IVUS?
    Starkey, IR
    [J]. HEART, 1997, 78 : 30 - 30
  • [2] Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
    Vergote, Ignace
    Amant, Frederic
    Leunen, Karin
    du Bois, Andreas
    Heitz, Florian
    Harter, Philipp
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 128 (01) : 6 - 11
  • [3] Colorectal stents: Do we have enough evidence?
    Al Samaraee, Ahmad
    McCallum, Iain J.
    Kenny, Louise
    Isreb, Siddek
    MacDougall, Louise
    Hayat, Mumtaz
    Kelly, Seamus
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2011, 9 (08) : 595 - 599
  • [4] DO WE HAVE ENOUGH EVIDENCE BASED SEXUAL TREATMENT FOR CANCER PATIENTS?
    Nesher, Peleg S.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S218 - S218
  • [5] Do we have enough evidence for adjuvant postoperative chemoradiation in esophageal cancer?
    Hsu, Po-Kuei
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1777 - 1779
  • [6] Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?
    Siegel, Robert
    [J]. JAMA ONCOLOGY, 2022, 8 (05) : 781 - 782
  • [7] Do we have enough?
    Horvath, Istvan T.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [8] Do we have enough evidence for approval of nadofaragene firadenovec?
    Akand, Murat
    Van der Aa, Frank
    Joniau, Steven
    [J]. MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (05): : 646 - 647
  • [9] Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?-Reply
    Fokas, Emmanouil
    Roedel, Claus
    [J]. JAMA ONCOLOGY, 2022, 8 (05) : 782 - 783
  • [10] Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
    Wezel, Felix
    Vallo, Stefan
    Roghmann, Florian
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (06) : 1067 - 1080
12345